208 related articles for article (PubMed ID: 21914854)
1. The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.
Zhao L; Yue P; Lonial S; Khuri FR; Sun SY
Mol Cancer Ther; 2011 Dec; 10(12):2415-25. PubMed ID: 21914854
[TBL] [Abstract][Full Text] [Related]
2. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
Fan S; Li Y; Yue P; Khuri FR; Sun SY
Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
[TBL] [Abstract][Full Text] [Related]
3. The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition.
Li B; Ren H; Yue P; Chen M; Khuri FR; Sun SY
Cancer Prev Res (Phila); 2012 Apr; 5(4):612-20. PubMed ID: 22345097
[TBL] [Abstract][Full Text] [Related]
4. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
Kim JH; Ajaz M; Lokshin A; Lee YJ
Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
[TBL] [Abstract][Full Text] [Related]
5. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
[TBL] [Abstract][Full Text] [Related]
6. The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition.
Yao W; Yue P; Khuri FR; Sun SY
Oncotarget; 2015 Oct; 6(33):34669-79. PubMed ID: 26415225
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis.
Chen S; Fu L; Raja SM; Yue P; Khuri FR; Sun SY
Mol Cancer; 2010 Jan; 9():23. PubMed ID: 20113484
[TBL] [Abstract][Full Text] [Related]
8. MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).
Li W; Zhang X; Olumi AF
Cancer Res; 2007 Mar; 67(5):2247-55. PubMed ID: 17332355
[TBL] [Abstract][Full Text] [Related]
9. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
[TBL] [Abstract][Full Text] [Related]
10. mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis.
Zhao L; Yue P; Khuri FR; Sun SY
Cancer Res; 2013 Mar; 73(6):1946-57. PubMed ID: 23319802
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
12. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
Raja SM; Chen S; Yue P; Acker TM; Lefkove B; Arbiser JL; Khuri FR; Sun SY
Mol Cancer Ther; 2008 Jul; 7(7):2212-23. PubMed ID: 18645030
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L).
Min KJ; Seo BR; Bae YC; Yoo YH; Kwon TK
Cell Death Dis; 2014 Feb; 5(2):e1063. PubMed ID: 24556678
[TBL] [Abstract][Full Text] [Related]
14. c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589.
Kauh J; Fan S; Xia M; Yue P; Yang L; Khuri FR; Sun SY
PLoS One; 2010 Apr; 5(4):e10376. PubMed ID: 20442774
[TBL] [Abstract][Full Text] [Related]
15. Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10.
Raulf N; El-Attar R; Kulms D; Lecis D; Delia D; Walczak H; Papenfuss K; Odell E; Tavassoli M
Br J Cancer; 2014 Nov; 111(10):1955-64. PubMed ID: 25314064
[TBL] [Abstract][Full Text] [Related]
16. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
17. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1.
Jang JH; Lee TJ; Yang ES; Min do S; Kim YH; Kim SH; Choi YH; Park JW; Choi KS; Kwon TK
Exp Cell Res; 2010 Aug; 316(13):2194-203. PubMed ID: 20451517
[TBL] [Abstract][Full Text] [Related]
18. Combination effects of SMAC mimetic birinapant with TNFα, TRAIL, and docetaxel in preclinical models of HNSCC.
Eytan DF; Snow GE; Carlson SG; Schiltz S; Chen Z; Van Waes C
Laryngoscope; 2015 Mar; 125(3):E118-24. PubMed ID: 25431358
[TBL] [Abstract][Full Text] [Related]
19. c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL.
Fu L; Lin YD; Elrod HA; Yue P; Oh Y; Li B; Tao H; Chen GZ; Shin DM; Khuri FR; Sun SY
Mol Cancer; 2010 Dec; 9():315. PubMed ID: 21172010
[TBL] [Abstract][Full Text] [Related]
20. The coffee diterpene kahweol sensitizes TRAIL-induced apoptosis in renal carcinoma Caki cells through down-regulation of Bcl-2 and c-FLIP.
Um HJ; Oh JH; Kim YN; Choi YH; Kim SH; Park JW; Kwon TK
Chem Biol Interact; 2010 Jun; 186(1):36-42. PubMed ID: 20403343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]